ArticlePLoS genetics2025
A genetic modifier links integrin α5 to the phenotypic variation in fibronectin 1a mutant zebrafish.
Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Phenotypic variation is often observed in individuals with the same mutation. However, the mechanisms that contribute to this variation remain largely unknown. Fibronectin mutants in both mouse and zebrafish fail to form a functional cardiovascular system, although the penetrance and expressivity of this phenotype vary depending on the genetic background. Here we investigate the variation of the zebrafish natter phenotype, which is caused by a nonsense mutation in fibronectin 1a (fn1a). natter/fn1a mutants exhibit incompletely penetrant cardia bifida, a phenotype caused by the failure of cardiac progenitors to migrate to the midline. To examine whether this variation is related to the nonsense mutation, we first generated a large deletion in fn1a that removes the proximal promoter and first 17 exons. Characterisation of this allele found that mutants display variable cardiac phenotypes indistinguishable from those observed in natter/fn1a mutants. As phenotypic variation is often associated with changes in paralogous gene expression, we next examined the expression of the fn1a paralogue, fn1b, and observed its upregulation specifically in the natter/fn1a mutants that exhibit a severe phenotype. However, overexpression and double mutant analyses suggest that fn1b expression levels do not modulate the natter/fn1a mutant phenotype. During these studies, we observed a small proportion of natter/fn1a mutants with a wild-type (WT)-like phenotype. Selectively raising WT looking mutant larvae increased the proportion of natter/fn1a mutants displaying the WT-like phenotype from 1.7% to 38.6% in just three generations, indicating the selection of a genetic modifier of the mutant phenotype. We mapped this modifier to the integrin alpha 5 (itgα5) locus through whole-genome sequencing. Furthermore, we found that manipulating itgα5 expression influenced the severity of the fn1a mutant phenotype, and that the variance in itgα5 expression was increased in fn1a mutants exhibiting a severe phenotype. Taken together, these results indicate that itgα5 modifies the fn1a mutant phenotype.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.